跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,162 条关于
“congenital HI”
全部
3,162
临床试验
2,699
药物
65
机构
13
资讯
385
去年
Ersodetug Receives FDA Breakthrough Therapy Designation for Congenital Hyperinsulinism
2年前
Amylyx Acquires Phase 3-Ready GLP-1 Receptor Antagonist Avexitide for Hyperinsulinemic Hypoglycemia
2年前
FDA Lifts Clinical Hold on Rezolute's Ersodetug for Congenital Hyperinsulinism, Allowing US Trial Enrollment
去年
Rezolute's Ersodetug Advances in Phase 3 Trials for Hyperinsulinism
去年
Rezolute's Ersodetug Advances in Phase 3 for Hyperinsulinism; RZ402 Shows Promise in DME
去年
Ersodetug Receives FDA Orphan Drug Designation for Tumor-Induced Hypoglycemia
9个月前
Rezolute's Phase 3 Trial for Congenital Hyperinsulinism Drug Fails to Meet Primary Endpoints
11个月前
First-in-Class FcRn Inhibitor Prevents Congenital Heart Block in High-Risk Pregnancy
去年
Amylyx Pharmaceuticals Advances Pipeline with Positive Data and Strategic Acquisitions
去年
LQT-1213 Receives FDA Orphan Drug Designation for Long QT Syndrome Treatment
第 1 页,共 39 页
上一页
下一页